Therapeutic Category
- Analgesic, Nonopioid
- Anti-inflammatory Agent
- Nonsteroidal Anti-inflammatory Drug (NSAID), Oral
Medication Safety Issues
Oxaprozin may be confused with oxazepam, OXcarbazepine
Beers Criteria: Oxaprozin is identified in the Beers Criteria as a potentially inappropriate medication to be avoided for chronic use in patients 65 years and older (unless alternative agents ineffective and patient can receive concomitant gastroprotective agent) due to increased risk of GI bleeding and peptic ulcer disease in older adults in high-risk category (eg, older than 75 years of age or receiving concomitant oral/parenteral corticosteroids, anticoagulants, or antiplatelet agents). In addition, avoid for short-term scheduled use in combination with oral/parenteral corticosteroids, anticoagulants, or antiplatelet agents unless alternatives are ineffective and patient can receive concomitant gastroprotective agent (Beers Criteria [AGS 2023]).
